Brucellosis

[unable to retrieve full-text content] CDC warns hunters of tuberculosis found in deer    WKRC TV Cincinnati https://ift.tt/2DkbwjS

CLOSE A brief explanation of what tuberculosis is and how it is transmitted. Wochit Since 2018, there have been at least three cases of large numbers of people being potentially exposed to tuberculosis in Delaware. They came at ManorCare health services in Wilmington, Georgetown Elementary in Sussex County and, most recently, at Bayhealth's Kent Campus.  They told the public about two, but not about the third case, which may have exposed 200 people at Bayhealth's Kent Campus. "Not everyone at the location was a risk," Dr. Rick Hong, state medical director, said about the Bayhealth exposure. "We don't want to create public fear." "Although that 200 number seems very large," he added, "it is very accurate." BACKGROUND: 200 people 'potentially exposed' to tuberculosis at Bayhealth in Dover According to the Centers for Disease Control and Prevention's guidelines for handling tuberculosis cases, states...

Tulane National Primate Research Center Director Jay Rappaport (right) and Skip Bohm, associate director and chief veterinary medical officer, will work on the research effort to help find a more effective vaccine against tuberculosis. Photo by Paula Burch-Celentano. The Tulane National Primate Research Center was awarded a $1.5 million grant from the Bill & Melinda Gates Foundation to help researchers find a more effective vaccine against tuberculosis. The grant will fund efforts to establish a nonhuman primate colony that more closely mimics the way people are currently vaccinated against the disease. Tuberculosis, the world’s leading infectious disease killer, claims millions of lives every year. Although much of the world’s population is vaccinated against tuberculosis at birth, an estimated one third of the world’s population is infected with  Mycobacterium tuberculosis . Despite nearly a century of use with limited effectiveness, the Bacillus Calmette-Guérin...

A study recently published by researchers in both Loma Linda and in the Southeast Asian nation of Laos found that respiratory health and rates of tuberculosis in low-income communities may be severely impacted by controllable external factors. Tuberculosis (TB) — a curable and preventable disease — is now the world’s leading cause of death from an infectious agent, surpassing HIV and AIDS. The study — published online by the International Journal of Environmental Research and Public Health — found that, in Laos, for every additional source of exposure to air pollution, the odds of TB go up 47%. Sources of air pollution considered included exposure to smoked tobacco, secondhand tobacco smoke, and smoke from indoor cooking fires, burning crop waste and burning trash outside. This study explored what exposure to multiple sources of air pollution did to impact rates of TB. Researchers said they hope the findings will lead to the engagement of multiple sectors of the society beyond h...

The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years postvaccination in participants with Mycobacterium tuberculosis , according to a study published in The New England Journal of Medicine. TB remains the leading cause of death from a single pathogen, according to the World Health Organization (WHO). Vaccines that are safe and effective against TB are key to ending this epidemic. The WHO has stated that new TB vaccines for patients with or without M tuberculosis infection should have at least 50% efficacy against bacteriologically confirmed TB and that this efficacy should be sustained for at least 2 years and, ideally, 10 years. The candidate vaccine M72/AS01 contains a recombinant fusion protein derived from 2 M tuberculosis antigens and is combined with the AS01 adjuvant system. A previous analysis of this trial (ClinicalTrials.gov identifier: NCT01755598 ) suggested that this vaccine provided 54.0% protection against active pulmonary TB disease ...

1. In this randomized trial involving HIV-negative African adults with latent tuberculosis, vaccination with M72/AS01E provoked an immune response and offered 50% protection against progression to active pulmonary tuberculosis. The rates of serious adverse events, potential immune-mediated diseases, and death were similar between groups. 2. Participants in Kenya and South Africa displayed different patterns of CD4+ T-cell expression, suggesting that cellular differentiation may have been affected by infection-related, vaccine-induced, and ethnic-group factors. Evidence Rating Level: 1 (Excellent) Study Rundown: Tuberculosis is the leading cause of death from a single pathogen and a top ten cause of death worldwide. M72/AS01E, an adjuvanted recombinant candidate vaccine, has previously been shown to be effective in preventing pulmonary tuberculosis in HIV-negative adults with latent M. tuberculosis infection in Kenya, South Africa, and Zambia. This study aimed to extend those res...

DOVER, Del. (CBS) — There’s a health alert in Kent County, Delaware. Health officials say about 200 people may have been exposed to tuberculosis at Bayhealth Hospital in Dover. The possible exposure happened between February and August of this year, but they didn’t say how the bacteria spread. The Delaware Department of Health says no current patients are at risk and the risk to the general public is minimal. You will get a letter if you may have been exposed.   https://ift.tt/2QKKx90

A new artificial intelligence (AI) platform created by researchers from the University of Michigan is capable of predicting how current tuberculosis treatments can be combined to create more effective solutions. This work was published in mBio and was supported by the National Institutes of Health (NIH) and the University of Michigan Precision Health and MCubed initiatives. “This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive,” explained research leader Sriram Chandrasekaran, an assistant professor of biomedical engineering at the University of Michigan. This software, INferring Drug Interactions using chemoGenomics and Orthology (INDIGO), has shown that the effectiveness of certain tuberculosis drugs can be enhanced when used in concert with unexpected compounds such as antipsychotics or antimalarials. “This tool can accurately predict the activity of drug combinations, including synergy—where the activity of...

Credit: CC0 Public Domain With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective treatments. "This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive," said Sriram Chandrasekaran, U-M assistant professor of biomedical engineering, who leads the research. Dubbed INDIGO, short for INferring Drug Interactions using chemoGenomics and Orthology, the software tool has shown that the potency of tuberculosis drugs can be amplified when they are teamed with antipsychotics or antimalarials. "This tool can accurately predict the activity of drug combinations, including synergy—where the activity of the combination is greater than the sum of the individual drugs," said Shuyi Ma, a research scientist at the University of Washington and a firs...

[unable to retrieve full-text content] Delaware health department warns of tuberculosis exposure    Raleigh News & Observer https://ift.tt/2QDEpiW

November 22, 2019 DOVER, Del. – The Delaware Department of Public Health says that roughly 200 people may have been exposed to Tuberculosis at a local hospital earlier this year. Officials confirmed on Thursday that the bacteria may have spread between February and August of this year at Bayhealth hospital in Dover. We’re told that this grouping of TB cases is considered a cluster and not an outbreak, as the number of cases of TB diagnosed in Delaware this year is no higher than at this time last year. Health division spokeswoman Jennifer Brestel says that no current Bayhealth patients are at risk, and there is minimal risk to the general public. She also says the department is contacting people who may have been exposed. Those who do not receive a letter do not need to worry. Tuberculosis is a bacterial disease that attacks the lungs, and can be spread by coughing and sneezing. For more information on Tuberculosis, click here . https://ift.tt/2OCvThj

Photo by John O'Boyle | The Daily Targum David Alland and Soumitesh Chakravorty at the 2019 Edison Patent Awards celebrating their work in biotechnology. On Nov. 14, two researchers from Rutgers University received the 2019 Edison Patent Award for biotechnology from the Research and Development Council of New Jersey for the development of a new Mycobacterium tuberculosis (TB) test, according to a press release.  Rutgers inventor David Alland, chief of the Division of Infectious Diseases at Rutgers New Jersey Medical School (NJMS) and director of the Center for Emerging Pathogens and Rutgers Regional Biocontainment Laboratory, worked with Soumitesh Chakravorty, adjunct assistant professor at NJMS and director of research and development at Cepheid Inc., to develop the new test, according to the release. Prior to their invention, it took approximately seven weeks to diagnose TB, according to the release. The new technology takes only 2 hours. The new test also works on dr...

With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs -- including unlikely candidates -- can be combined in new ways to create more effective treatments. "This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive," said Sriram Chandrasekaran, U-M assistant professor of biomedical engineering, who leads the research. Dubbed INDIGO, short for INferring Drug Interactions using chemoGenomics and Orthology, the software tool has shown that the potency of tuberculosis drugs can be amplified when they are teamed with antipsychotics or antimalarials. "This tool can accurately predict the activity of drug combinations, including synergy -- where the activity of the combination is greater than the sum of the individual drugs," said Shuyi Ma, a research scientist at the University of Washington and a first author of the study. ...

CLOSE A brief explanation of what tuberculosis is and how it is transmitted. Wochit About 200 people were "potentially exposed" to tuberculosis at Bayhealth in Dover from February to August, health officials said Thursday afternoon. There is no "evidence of uncontrolled spread of the bacteria" and there is "no risk to current patients at the hospital as a result of this exposure," Division of Public Health spokeswoman Jennifer Brestel wrote in an email.  The state wants to "strongly emphasize that the risk to the general public is minimal," she wrote. The health department is in the process of contacting people who might have been exposed, she said.  Bayhealth officials said in statement that the health system has and will "continue to work very closely with our partners at Delaware Public Health to identify patients who may have been exposed." "It’s important to note the risk of exposure is low," hospit...

The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years postvaccination in participants with Mycobacterium tuberculosis , according to a study published in The New England Journal of Medicine. TB remains the leading cause of death from a single pathogen, according to the World Health Organization (WHO). Vaccines that are safe and effective against TB are key to ending this epidemic. The WHO has stated that new TB vaccines for patients with or without M tuberculosis infection should have at least 50% efficacy against bacteriologically confirmed TB and that this efficacy should be sustained for at least 2 years and, ideally, 10 years. The candidate vaccine M72/AS01 contains a recombinant fusion protein derived from 2 M tuberculosis antigens and is combined with the AS01 adjuvant system. A previous analysis of this trial (ClinicalTrials.gov identifier: NCT01755598 ) suggested that this vaccine provided 54.0% protection against active pulmonary TB disease ...

Brii Biosciences has licensed the greater China rights to AN2 Therapeutics’ clinical-stage tuberculosis drug. The deal is part of a broader push by Brii to use some of the $260 million it raised last year to bring new antibiotics to patients. Antibiotic R&D has become a biopharma backwater, with a limited number of companies committing to the field and those that do being rewarded with an inhospitable commercial environment. Yet Brii, one of the biggest biotech launches of 2018, has made antibiotic R&D one of the pillars of its pipeline, leading to a deal spree that has seen it pick up rights to seven assets. Brii’s willingness to invest in antibiotics is in part a reflection of its function as a bridge between the U.S. and China. As Brii CEO Zhi Hong sees it, multidrug resistance (MDR) is yet to become common enough in the U.S. to drive use of new antibiotics. The situation in China may be different.  FREE DAILY NEWSLETTER Like this story? Subscribe to FierceBiot...

There is a confirmed case of tuberculosis at Bernice MacNaughton High School in Moncton. Public Health "recently" informed the school about the infected "member of the school community" and is investigating, according to a letter to students, parents and guardians on Wednesday. No information about the individual has been released. Tuberculosis, or TB, is an infection of the lungs caused by the bacteria  mycobacterium tuberculosis  and is spread from person to person through the air. When someone with active TB coughs, sneezes, or sometimes even talks, tiny droplets containing TB germs are released into the air, where they can remain for hours. TB usually attacks the lungs, but can also affect other parts of the body, such as the brain, kidneys, lymph nodes and spine. If left untreated, it can lead to death. "Fortunately, tuberculosis is usually not very contagious, unlike many other infections, such as pertussis, the common cold or influenza," the...

Video Player Close BEIJING, Nov. 20 (Xinhua) -- China's National Health Commission (NHC) and the Bill & Melinda Gates Foundation on Wednesday signed a memorandum of understanding (MoU) on the prevention and control of tuberculosis. Aiming to promote new tools, technologies and strategies to counter the epidemic, the deal was made at a seminar in celebration of the 10th anniversary of the cooperation program of the two sides. According to the memorandum, an innovative tuberculosis control program will be implemented in selected provincial-level regions utilizing new technologies for diagnosis and patient management, with new models for designated hospitals and new financing approaches to minimize healthcare expenses. The NHC and the foundation will also work together to refine existing policies and approaches concerning the disease while developing new ones in support of the country's national action plan to stop tuberculosis. Hailing the success the NHC-Gates Found...

Following the launch in 2018 of the United Nations Common Position on Ending HIV, TB and Viral Hepatitis through Intersectoral Collaboration, Belarus, Georgia, Portugal and Tajikistan agreed to lead the way on adopting an intersectoral approach in their response to the 3 diseases. The Common Position, signed by 14 United Nations agencies, addresses the social, economic and environmental determinants of the 3 epidemics through action in areas outside the health sector. It builds on what works in each context to address unmet needs, while systematically advancing all Sustainable Development Goals. The 4 pilot countries have already developed some forms of cooperation between sectors, particularly with the social sector, local governance and nongovernmental organizations (NGOs) that provide different forms of support to patients suffering from these diseases or under long-term treatment. These range from providing financial aid and food aid to ensuring patients’ protection in social ne...

COLUMBIA, S.C. — Lexington Medical Center has confirmed that both the hospital and the South Carolina Department of Health have completed initial testing on anyone who may have encountered a patient infected with tuberculosis. TB is an infection caused by a type of bacteria called Mycobacterium tuberculosis ( M. tuberculosis ). Generally, to contract TB, you need to be in close contact with someone who has active TB for a prolonged period. That is because the bacteria that causes tuberculosis spreads when uninfected people breath in the contaminated air after an infected person coughs, sneezes or speaks.  Anyone can catch tuberculosis. In fact, according to the World Health Organization, an estimates 1.8 billion people are infected globally. What are the symptoms of TB?  TB usually doesn’t cause symptoms immediately and typical you get sick in three stages. First, while you may have been exposed, you may not get sick because a healthy immune system does its job of fight...